OA06599A - Procédé de préparation d'un agent pour le traitement de théilérioses. - Google Patents

Procédé de préparation d'un agent pour le traitement de théilérioses.

Info

Publication number
OA06599A
OA06599A OA57198A OA57198A OA06599A OA 06599 A OA06599 A OA 06599A OA 57198 A OA57198 A OA 57198A OA 57198 A OA57198 A OA 57198A OA 06599 A OA06599 A OA 06599A
Authority
OA
OAPI
Prior art keywords
theileroses
agent
preparation
treatment
Prior art date
Application number
OA57198A
Other languages
English (en)
French (fr)
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of OA06599A publication Critical patent/OA06599A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
OA57198A 1979-08-23 1980-08-22 Procédé de préparation d'un agent pour le traitement de théilérioses. OA06599A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19792934069 DE2934069A1 (de) 1979-08-23 1979-08-23 Mittel gegen theileriosen und seine verwendung.

Publications (1)

Publication Number Publication Date
OA06599A true OA06599A (fr) 1981-08-31

Family

ID=6079087

Family Applications (1)

Application Number Title Priority Date Filing Date
OA57198A OA06599A (fr) 1979-08-23 1980-08-22 Procédé de préparation d'un agent pour le traitement de théilérioses.

Country Status (14)

Country Link
US (1) US4340596A (xx)
BE (1) BE884917A (xx)
CH (1) CH649545A5 (xx)
DE (1) DE2934069A1 (xx)
EG (1) EG14600A (xx)
FR (2) FR2468368A1 (xx)
GB (1) GB2057439B (xx)
IL (1) IL60890A (xx)
KE (1) KE3382A (xx)
MA (1) MA18939A1 (xx)
MW (1) MW3080A1 (xx)
OA (1) OA06599A (xx)
ZM (1) ZM6780A1 (xx)
ZW (1) ZW19680A1 (xx)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1155358B (it) * 1982-07-06 1987-01-28 Vetem Spa Derivati chinazolinonici attivi contro la coccidiosi
US4906635A (en) * 1983-11-25 1990-03-06 Schering Corporation Carboxyalkyl dipeptides as antiglaucoma agents
US4778795A (en) * 1983-11-25 1988-10-18 Schering Corporation Carboxyalkyl dipeptides as antiglaucoma agents
US5017567A (en) * 1983-11-25 1991-05-21 Schering Corporation Carboxyalkyl dipeptides as antiglaucoma agents
US4762838A (en) * 1985-08-30 1988-08-09 Pfizer Inc. Quinazolin-4(3H)-one derivatives as anticoccidial agents
US4797486A (en) * 1986-09-08 1989-01-10 Pfizer Inc. Heterocyclic ring fused pyrimidine-4(3H)-ones as anticoccidial agents
DE3638445A1 (de) * 1986-11-11 1988-05-26 Hoechst Ag Coccidiozide mittel
US4849518A (en) * 1987-06-22 1989-07-18 Pfizer Inc. Quinazolin-4(3H)-one derivatives as anticoccidial agents
US4920224A (en) * 1988-03-24 1990-04-24 Pfizer Inc. Quinazolin-4(3H)-one derivatives as anticoccidial agents
AU3467493A (en) * 1992-01-27 1993-09-01 Board Of Trustees Of The Leland Stanford Junior University Histamine derivatives and methods for their use
IL110831A (en) * 1994-08-31 1998-12-27 Hadasit Med Res Service Pharmaceutical compositions containing quinazolinone derivatives for preventing restenosis
US5998422A (en) * 1994-12-12 1999-12-07 Agricultural Research Organization, Ministry Of Agriculture Quinazolinone-containing pharmaceutical compositions and methods for the use thereof
IL112125A (en) * 1994-12-22 1998-02-08 Hadasit Med Res Service Quinazolinone-containing pharmaceutical compositions
US6090814A (en) * 1995-08-15 2000-07-18 Agricultural Research Organization Ministry Of Agriculture Quinazolinone-containing pharmaceutical compositions for prevention of neovascularization
IL114951A (en) * 1995-08-15 1999-08-17 Hadasit Med Res Service Quinazolinone-containing pharmaceutical compositions for prevention of neovascularization
DE69714281T2 (de) * 1996-08-30 2003-02-27 Agricultural Res Org Intracoronarer stent der quinazolinone derivate enthält
US6028075A (en) * 1997-02-11 2000-02-22 Pines; Mark Quinazolinone containing pharmaceutical compositions for prevention of neovascularization and for treating malignancies
US6159488A (en) * 1997-08-14 2000-12-12 Agricultural Research Org. Ministry Of Agriculture (Gov.) Intracoronary stents containing quinazolinone derivatives
DE69927987T2 (de) * 1998-08-13 2006-11-09 Hadasit Medical Research Services & Development Co. Ltd. Hemmung von mit gewebetrauma verbundenen pathogenen prozessen
IL148292A (en) * 2002-02-21 2008-08-07 Shai Yarkoni Stable preparations of lupoginone and other quinazolinone derivatives
WO2006090376A2 (en) * 2005-02-23 2006-08-31 Collgard Biopharmaceuticals Ltd. Pharmaceutical compositions of the isolated d- enantiomer of the quinazolinone derivative halofuginone
WO2007120606A2 (en) * 2006-04-10 2007-10-25 President And Fellows Of Harvard College Methods for modulating formation and progression of cellulite
WO2009023267A2 (en) * 2007-08-15 2009-02-19 President And Fellows Of Harvard College Methods for modulating development and expansion of il-17 expressing cells
US9284297B2 (en) 2008-08-11 2016-03-15 President And Fellows Of Harvard College Halofuginone analogs for inhibition of tRNA synthetases and uses thereof
WO2013106702A1 (en) 2012-01-13 2013-07-18 President And Fellows Of Harvard College Halofuginol derivatives and their use in cosmetic and pharmaceutical compositions
EP2845588A1 (en) * 2013-09-09 2015-03-11 Centre National de la Recherche Scientifique (C.N.R.S.) PIN1 inhibitors for use in the prevention and/or treatment of theileriosis, and related applications
EP3801525A4 (en) 2018-06-08 2022-03-23 The General Hospital Corporation PROLYL-ARNT-SYNTHETASE INHIBITORS

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE505711A (xx) * 1950-09-09
US2694711A (en) * 1952-12-02 1954-11-16 American Cyanamid Co Quinazolone antimalarial compounds
US3320124A (en) * 1964-07-20 1967-05-16 American Cyanamid Co Method for treating coccidiosis with quinazolinones

Also Published As

Publication number Publication date
US4340596A (en) 1982-07-20
IL60890A0 (en) 1980-10-26
ZM6780A1 (en) 1981-10-21
IL60890A (en) 1983-09-30
GB2057439B (en) 1983-06-22
CH649545A5 (de) 1985-05-31
EG14600A (en) 1985-03-31
DE2934069A1 (de) 1981-03-12
FR2468602A1 (fr) 1981-05-08
FR2468602B1 (xx) 1983-07-22
DE2934069C2 (xx) 1990-02-15
MA18939A1 (fr) 1981-04-01
MW3080A1 (en) 1981-08-12
FR2468368A1 (fr) 1981-05-08
BE884917A (fr) 1981-02-25
FR2468368B1 (xx) 1983-07-08
ZW19680A1 (en) 1981-03-11
KE3382A (en) 1984-03-23
GB2057439A (en) 1981-04-01

Similar Documents

Publication Publication Date Title
OA06599A (fr) Procédé de préparation d'un agent pour le traitement de théilérioses.
OA06914A (fr) Procédé de préparation d'iminodiacides substitués.
BE851328A (fr) Composition pour le traitement de l'hypercholesterolemie
DZ473A1 (fr) Dérivés de l'acide cis-endo-2-azabicyclo/3,3,o/-octane-3-carboxylique, procédé pour leur préparation, agents contenant ces dérivés et leur utilisation.
BE890648A (fr) Compositions pour le traitement de l'acne
OA06930A (fr) Procédé de préparation d'acides aza-bicyclo-octane carboxyliques.
OA06563A (fr) Procédé de préparation de nouveaux dérivés d'indolizine.
OA06486A (fr) Procédé de préparation de 9 aminoalkylfluorènes.
RO81474A (ro) Procedeu pentru prepararea interferonei omogene din fibroplaste umane
RO72547A (ro) Procedeu pentru prepararea unor esteri 2',3,6'-triclor-4-cian-4'-benzoilureidodifenilici
OA06701A (fr) Procédé de traitement d'un phosphate aluminocalcique.
BE850383A (fr) Procede ameliore pour le dosage de l'alcoolemie
OA07202A (fr) Procédé pour la préparation de l'urée
OA07984A (fr) Procédé stéréocontrolé de préparation d'acetoxyazetidione.
BE873092A (fr) Composition pour le traitement de l'hypertension
OA05260A (fr) Procédé de préparation de dérivés d'histidine.
BE858692A (fr) Composition pour le traitement de l'acne
FR2536995B1 (fr) Composition pour le traitement de l'arthrite
OA06355A (fr) Procédé de préparation de 3-exométhylènecépham-sulfoxydes.
FR2340737A1 (fr) Composition pour le traitement de l'hypercholesterolemie
OA06284A (fr) Procédé de préparation de compositions pour le traitement d'infections chroniques de trypanosomiase.
BE894228A (fr) Composition pharmaceutique pour le traitement de l'atherosclerose
BE867228A (fr) Procede pour la preparation d'hydroxyphenylglycocolles
BE867414A (fr) Procede pour la preparation d'hydroxy-alpha-aminobenzylpenicillines
BE880031A (fr) Procede pour la preparation de 1 alpha, 3 beta-dihydroxy-delta 5-steroides